Rostafuroxin

DB12350InvestigationalSmall molecule

Rostafuroxin has been used in trials studying the treatment of Essential Hypertension.

Chemical structure of Rostafuroxin
Formula / weight
C23H34O4 · 374.521 g/mol (avg)

Resolves to

Compound
UNIIP848LCX62BCAS156722-18-8ChEMBLCHEMBL2068971PubChem153976
Clinical / RWD
PharmGKBPA166129554
Structure
InChIKeyAEAPORIZZWBIEX-DTBDINHYSA-NSMILESC[C@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@]34C)[C@@]1(O)CC[C@]2(O)C1=COC=C1
Targets
P54709ATP1B3P14415ATP1B2P05026ATP1B1P13637ATP1A3P50993ATP1A2P05023ATP1A1

What you can answer from here — as of January 29, 2025

6Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Rostafuroxin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In